Predictive analysis of multiple future scientific impacts by embedding a heterogeneous network. [PDF]
PLoS One, 2022 Ochi M, Shiro M, Mori J, Sakata I.
europepmc +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background and Purpose White matter hyperintensities (WMH) are a core neuroimaging marker of cerebral small vessel disease (CSVD). Sleep apnoea (SA) is a recognized vascular risk factor, but its associations with regional WMH burden, short‐interval WMH change and cognitive performance in population‐based cohorts remain incompletely defined. We
Peng Cheng +4 more
wiley +1 more source
MetaMDA: explainable prediction of microbe-drug association utilizing random walks on a microbe-metabolite-drug heterogeneous network. [PDF]
BioinformaticsWang Q, Chen S, Miao X, Liu Y, Liu B.
europepmc +1 more source
Fractional model for Middle East respiratory syndrome coronavirus on a complex heterogeneous network. [PDF]
Sci Rep, 2022 El-Saka HAA, Obaya I, Lee S, Jang B.
europepmc +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Introduction Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have demonstrated significant weight‐reducing effects and may offer benefits in idiopathic intracranial hypertension (IIH); however, recent concerns about the risk of non‐arteritic anterior ischemic optic neuropathy (NAION) have emerged.
Faisal A. Al‐Harbi +9 more
wiley +1 more source
THGC_MDA: a method for predicting the associations between m<sup>1</sup>A modification and diseases based on ternary heterogeneous network and graph convolutional neural network. [PDF]
Front GenetGao H, Zhou X, Bai L, Yang H, Liu F.
europepmc +1 more source
A novel bi-directional heterogeneous network selection method for disease and microbial association prediction. [PDF]
BMC Bioinformatics, 2022 Guan J, Zhang ZG, Liu Y, Wang M.
europepmc +1 more source
Movement Disorders in Aicardi–Goutières Syndrome and Response to Immunomodulation
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT This study characterizes movement disorders and treatment responses in seven children with Aicardi–Goutières syndrome (AGS). We retrospectively evaluated motor phenotypes, neuroimaging, and interferon signatures in patients treated with baricitinib or anifrolumab. Spasticity affected all patients, while dystonia was present in 4/7.
Enrique Gonzalez Saez‐Diez +10 more
wiley +1 more source
Protein function prediction using GO similarity-based heterogeneous network propagation. [PDF]
Sci RepHu S, Zhao B.
europepmc +1 more source
Recommendation algorithm based on attributed multiplex heterogeneous network. [PDF]
PeerJ Comput Sci, 2021 Yang Z, Cheng J.
europepmc +1 more source